Email this article Acute myeloid leukemia in a chronic lymphocytic leukemia patient: diagnostic challenge (clinical case).
- Authors: Fernandes M.1, Martins J.1, Campos M.2, Magalhães C.2, Eremina Y.O.3,4
-
Affiliations:
- Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,EPE
- Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE
- Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE, Matosinhos
- Institute of Public Health of the University of Porto
- Issue: Vol 29, No 1 (2021)
- Pages: 130-133
- Section: Clinical reports
- URL: https://journals.rcsi.science/pavlovj/article/view/61145
- DOI: https://doi.org/10.23888/PAVLOVJ2021291130-133
- ID: 61145
Cite item
Open Access
Access granted
Subscription Access
Abstract
Chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) coexistence in the same patient has been rarely reported, more frequently due to treatment with chemotherapeutic agents. Blood parameter changes in cancer patients may be interpreted as disease progression or iatrogenic effects related to aggressive treatment, leading to delayed diagnosis. In our article, we call attention to the possibility of AML development in CLL patients and its diagnostic challenge.
Full Text
##article.viewOnOriginalSite##About the authors
Marta Sofia Fernandes
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,EPE
Author for correspondence.
Email: martascf23@gmail.com
ORCID iD: 0000-0003-1900-1639
MD, Resident in Clinical Pathology
Portugal, Matosinhos, PortugalJoana Martins
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,EPE
Email: JoanaMaria.Martins@ulsm.min-saude.pt
MD, Specialist in Clinical Hematology, Department of Clinical Hematology
Portugal, Matosinhos, PortugalMaria Antónia Campos
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE
Email: antonia.campos@ulsm.min-saude.pt
ORCID iD: 0000-0001-8016-8660
MD, Consultant in Clinical Pathology, Department of Clinical Pathology
Portugal, Matosinhos, PortugalCacilda Magalhães
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE
Email: cacilda.magalhaes@ulsm.min-saude.pt
ORCID iD: 0000-0001-7407-4908
MD, Consultant in Clinical Pathology, Director of the Department of Clinical Pathology
Portugal, Matosinhos, PortugalYuliana O. Eremina
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE, Matosinhos; Institute of Public Health of the University of Porto
Email: yuliana.eremina@ulsm.min-saude.pt
ORCID iD: 0000-0002-3656-7266
ResearcherId: ABD-8614-2020
MD, PhD, Specialist in Clinical Pathology, Assistant of the Department of Clinical Pathology, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE, Matosinhos; Collaborator of Environmental and Laboratorial Epidemiology Research Group (EPIUnit), Environmental Health Department
Portugal, Matosinhos, PortugalReferences
- Giri S, Bhatt VR, Khanal S, et al. Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine? Therapeutic Advances in Hematology. 2015;6(2):88-92. doi:10. 1177/2040620714566567
- Al Mussaed E, Osman H, Elyamany G. Simultaneous existence of acute myeloid leukemia and chronic lymphocytic leukemia: a case report. BMC Cancer. 2016;16(1):739. doi: 10.1186/s12885-016-2780-5
- Dong Q, Xiu Y, Bossler A, et al. CLL dedifferentiation to clonally related myeloid cells. Blood Advances. 2020;4(24):6169-74. doi: 10.1182/blood advances.2020002726
- Schoorl M, Schoorl M, Chevallier M, et al. Flagging performance of the Sysmex XN2000 haematology analyser. International Journal of Laboratory Hematology. 2016;38(2):160-6. doi:10.1111/ ijlh.12461
- Furundarena JR, Sainz M, Uranga A, et al. Comparison of abnormal cell flagging of the hematology analyzers Sysmex XN and Sysmex XE-5000 in oncohematologic patients. International Journal of Laboratory Hematology. 2017;39(1):58-67. doi:10. 1111/ijlh.12575
- Eilertsen H, Saether PC, Henriksson CE, et al. Evaluation of the detection of blasts by Sysmex hematology instruments, CellaVision DM96, and manual microscopy using flow cytometry as the confirmatory method. International Journal of Laboratory Hematology. 2019;41(3):338-44. doi: 10.1111/ijlh.12980
Supplementary files
